UniPharma Co., Ltd. (TPEX:6621)

UniPharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	20.09	29	58.68	68.64	63.76	75.96
Short-Term Investments	87.5	106.36	98.5	98.5	98.5	99.5
Cash & Short-Term Investments	107.59	135.36	157.18	167.14	162.26	175.46
Cash Growth	-25.61%	-13.88%	-5.96%	3.01%	-7.52%	-6.72%
Accounts Receivable	13.05	14.87	16.72	21.07	34.1	22.68
Other Receivables	0.16	0.14	0.13	0.18	0	0.3
Receivables	13.21	15.01	16.86	21.25	34.11	22.98
Inventory	30.68	31.3	22.27	28.94	31.05	35.94
Prepaid Expenses	-	-	-	0.06	0.32	-
Other Current Assets	3.72	2.81	3.71	8.83	10.56	27.01
Total Current Assets	155.19	184.47	200.01	226.23	238.28	261.39
Property, Plant & Equipment	19.1	18.56	23.79	11.57	8.73	13.46
Long-Term Investments	50.8	61.33	94.3	101.26	73.58	59.09
Other Intangible Assets	3.19	3.54	3.58	1.94	2.22	2.53
Other Long-Term Assets	7.04	7.1	7.3	9.07	9.77	11.71
Total Assets	235.32	274.99	328.98	350.07	332.57	348.18

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	13.55	18.05	14.49	22.25	6.09	27.66
Accrued Expenses	8.38	11.11	8.83	-	0.59	-
Current Portion of Leases	5.81	3.7	3.71	0.27	3.26	3.46
Current Unearned Revenue	2.36	2.51	2.57	2.72	3.12	2.41
Other Current Liabilities	1.91	2.57	3.56	11.87	15.71	13.27
Total Current Liabilities	32.01	37.94	33.15	37.12	28.78	46.8
Long-Term Leases	6.5	7.27	11.07	-	0.27	3.53
Other Long-Term Liabilities	-	-	-	0.29	0.29	0.29
Total Liabilities	38.52	45.2	44.22	37.4	29.33	50.61

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	355.01	355.01	355.01	355.01	355.01	355.01
Additional Paid-In Capital	0.38	0.38	0.38	0.38	0.38	17.94
Retained Earnings	-152.25	-128.56	-88.93	-60.92	-40.34	-51.39
Treasury Stock	-	-	-	-	-	-3.91
Comprehensive Income & Other	-6.34	2.96	18.29	18.2	-11.8	-20.08
Shareholders' Equity	196.8	229.79	284.75	312.67	303.24	297.57
Total Liabilities & Equity	235.32	274.99	328.98	350.07	332.57	348.18

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	12.32	10.96	14.78	0.27	3.53	6.99
Net Cash (Debt)	95.27	124.39	142.4	166.87	158.73	168.46
Net Cash Growth	-27.73%	-12.64%	-14.67%	5.13%	-5.78%	-1.63%
Net Cash Per Share	2.68	3.50	4.01	4.70	4.47	4.79
Filing Date Shares Outstanding	35.5	35.5	35.5	35.5	35.5	35.2
Total Common Shares Outstanding	35.5	35.5	35.5	35.5	35.5	35.2
Working Capital	123.18	146.54	166.86	189.11	209.51	214.59
Book Value Per Share	5.54	6.47	8.02	8.81	8.54	8.45
Tangible Book Value	193.6	226.25	281.17	310.73	301.03	295.04
Tangible Book Value Per Share	5.45	6.37	7.92	8.75	8.48	8.38
Machinery	30.32	29.85	28.62	28.14	20.03	19.88
Leasehold Improvements	-	-	-	-	-	0.38

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 7, 2026

Data Sources Report a data error